The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Charles Hennemeyer

Charles Hennemeyer

Associate Professor, Medical Imaging - (Clinical Scholar Track)

Medical Imaging
Map Page
9+ Collaborators
$43.1K / $43.1K Funding
40+ Publications

Research Area

cryoablation, pulmonary embolism, medical devices, catheter-directed therapy, hepatocellular carcinoma, medical imaging, embolization, cholecystitis, vascular intervention, perfusion angiography, interventional radiology

    Chart
    Bar chart with 12 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 16.
    End of interactive chart.
    Recent

    A Novel Method of Calculating the Tumor to Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-D Perfusion Angiography and Tc-99m MAA SPECT/CT.

    2023
    radioembolization, hepatocellular carcinoma, perfusion angiography, spect/ct

    Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial ILLUMINATE-101)

    2022
    cancer immunotherapy, antigen presentation, tlr9 pathway, type 1 ifn signaling, clinical trial

    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic 90Y Radioembolization Using SPECT/CT Versus Planar Scintigraphy.

    2022
    radiopharmaceuticals, medical imaging, radioembolization, dosimetry, clinical implications

    Safety and Feasibility of a Novel Percutaneous Locoregional Injection Technique of Renal Cellular Therapy for Chronic Kidney Disease of Diabetes.

    2021
    renal cellular therapy, chronic kidney disease, percutaneous injection, diabetes, safety

    Cardiac MRI for Evaluation of Right Heart Function before and after Catheter-directed Therapy in Submassive Pulmonary Embolism: A Prospective Study of Feasibility and Potential Utility.

    2021
    cardiac mri, catheter-directed therapy, pulmonary embolism

    Abstract No. 3 ▪ FEATURED ABSTRACT Clinical predictors of Yttrium-90 uptake in hepatocellular carcinoma: toward personalized dosimetry to maximize response to therapy

    2021
    hepatocellular carcinoma, yttrium-90, personalized dosimetry, clinical predictors, therapy response

    Gallbladder Cryoablation: A Novel Option for High-Risk Patients with Gallbladder Disease.

    2021
    cryoablation, gallbladder disease, high-risk patients, novel treatment, gallbladder surgery

    Abstract No. 34 Planar scintigraphy overestimates hepatopulmonary shunt fractions compared with quantitative SPECT/CT

    2021
    nuclear medicine, medical imaging, hepatology, quantitative analysis, diagnostic imaging

    Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography

    2021
    hemodynamics, nitroglycerin, hepatocellular carcinoma, perfusion angiography, quantitative assessment

    Tilsotolimod: an investigational synthetic toll-like receptor 9 TLR9) agonist for the treatment of refractory solid tumors and melanoma

    2021
    cancer immunotherapy, toll-like receptor 9, solid tumors, melanoma, drug development

    Page 1 of 2

    Charles Hennemeyer | KMap Profile - Institutional Knowledge Map (KMap)